Reply to 'HPV-associated oropharyngeal cancer - discussion points'

Nat Rev Clin Oncol. 2022 Jun;19(6):422-423. doi: 10.1038/s41571-022-00627-z.

Matt Lechner^{1

2

3}, Jacklyn Liu⁴, Liam Masterson⁵, Tim R Fenton^{6

7}

¹ UCL Cancer Institute, University College London, London, UK. m.lechner@ucl.ac.uk.
² UCL Head & Neck Academic Centre, Division of Surgery and Interventional Science, University College London, London, UK. m.lechner@ucl.ac.uk.
³ Department of ENT, Barts Health NHS Trust, London, UK. m.lechner@ucl.ac.uk.
⁴ UCL Cancer Institute, University College London, London, UK.
⁵ Department of ENT, Cambridge University Hospitals NHS Trust, Cambridge, UK.
⁶ School of Biosciences, University of Kent, Canterbury, UK. t.fenton@soton.ac.uk.
⁷ School of Cancer Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK. t.fenton@soton.ac.uk.

No abstract available

Publication types